Key Quantitative Figures
- Total preferential issue size: ₹1,650.00 lakh
- Total funds received during the quarter ended March 31, 2026: ₹1,018.88 lakh
- Amount received from allotment of 20,000,000 warrants (25% upfront payment): ₹412.50 lakh
- Amount received from allotment of 9,800,000 equity shares upon warrant conversion (75% balance): ₹606.38 lakh
- Fund allocation for expansion of business: ₹825.00 lakh
- Fund allocation for investment in projects: ₹412.50 lakh
- Fund allocation for general corporate purposes: ₹412.50 lakh
Dates of Action
- Date of warrant allotment: March 19, 2026
- Date of equity share allotment upon warrant conversion: March 28, 2026
- Date of disclosure submission: May 25, 2026
Financial and Operational Impact
The disclosure confirms there is no deviation or variation in the utilization of funds raised. The funds received during the quarter have not been utilized yet. The company states that the amount will be utilized in the upcoming Financial Year 2026-27 for the originally stated objects: business expansion (₹825.00 lakh), investment in projects (₹412.50 lakh), and general corporate purposes (₹412.50 lakh).
Audit Committee Review
The Audit Committee reviewed the statement and confirmed the receipt of funds. They noted the receipt of ₹412.50 lakh as a 25% upfront payment for 20,000,000 warrants and ₹606.38 lakh as the 75% balance subscription amount upon the allotment of 9,800,000 equity shares from warrant conversion.
Auditor Comments
The auditors provided no comments on the statement.